Navigation Links
Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
Date:5/16/2008

Single Molecule with Dual Mechanism May Offer Novel Approach to Blood

Pressure Management

NEW ORLEANS, May 16 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that PS433540, its first-in-class Dual Acting Receptor Antagonist (DARA), showed statistically significant blood pressure reductions in a Phase 2a study in patients with mild to moderate hypertension. PS433540 is being developed as a potential treatment for both hypertension and diabetic nephropathy and is a novel blood pressure product candidate that possesses two validated mechanisms of action in a single molecule. The data will be presented today at the Recent and Late Breaking Clinical Trials Session at the American Society of Hypertension (ASH) Twenty-Third Annual Scientific Meeting and Exposition in New Orleans.

The Phase 2a study met its primary endpoint by showing a statistically significant reduction in mean 24-hour systolic ambulatory blood pressure over placebo. The study also showed statistically significant improvements over placebo in mean 24-hour diastolic ambulatory blood pressure as well as seated blood pressure. In this double-blind, placebo-controlled study, patients treated with 200 mg of PS433540 once daily experienced a 12/9mmHg drop in mean 24-hour systolic and diastolic blood pressure and those treated with 500 mg experienced a 15/10mmHg drop in mean 24-hour systolic and diastolic blood pressure. These reductions were highly statistically significant vs. placebo (P<0.001). Mean seated office systolic and diastolic blood pressure, the typical blood pressure measure, was also evaluated, with observed blood pressure drops of 17/11mmHg with the 200 mg dose and 17/10mmHg with the 500 mg dose (P<0.001 vs. placebo).

Once-daily treatment with 200 or 500 mg of PS433540 was well tolerated. Most of the adverse events reported were mild o
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
2. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
3. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
4. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
5. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
6. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
7. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
8. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
9. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
10. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
11. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Nov. 6 Watson Pharmaceut...rmaceutical company, announced today that Paul Bis...r, will provide an overview and update of the Comp...althcare Conference on Wednesday, November 11, 200...esentation will be webcast live and can be accesse...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Caraco Pharmaceutical Labo...orolac tromethamine ophthalmic solution, 0.5% foll...dministration (FDA) for Sun Pharma,s Abbreviated N...; ophthalmic solution on the first day following p...erapeutically equivalent to Acular® Ophthalmi...
(Date:11/6/2009)...Nov. 6 Facet Solutions, Inc. annou...of Archus Orthopedics. The acquisition creates an ...s, intellectual property and clinical experience i...r patients suffering from lumbar spinal stenosis,"...f Pardo. "This consolidation further strengthens ...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Facet Solutions Acquires Archus Orthopedics 2American Association of Poison Control Centers 3A Count U S Poison Centers Among First Responders in H1N1 Flu Pandemic 60256 1American Association of Poison Control Centers 3A Count U S Poison Centers Among First Responders in H1N1 Flu Pandemic 60256 2VitaminSpice Appoints Dr Richard F Seelig as Director 5795 1VitaminSpice Appoints Dr Richard F Seelig as Director 5795 2Educating the Marketplace to Support Successful Oncology Product Launches 5790 1Educating the Marketplace to Support Successful Oncology Product Launches 5790 2
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasd...ata Safety Monitoring Board (DSMB) has determined ...or the treatment of acute ischemic stroke are unli... terminated further enrollment in,the trials. NTI ... the,potential for any future development of Vipri...
...ication of a Canadian study on colonoscopy,s impac... impact on mortality than previously reported. Phy...enterology urge patients and the public to recogni... case-control study have produced accurate data, c...etection of precancerous colon polyps and the only...
Other Medicine Technology:Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology 2
(Date:11/8/2009)...re/ -- The following was released today by Randall... ,, Mr. Terry and his associates from around t...g by abortion out of any health care bill for mont... step to victory -- a touchdown in the first quart...ur rejoicing must be tempered by reality. The Sena...
(Date:11/8/2009)...Working Families vs. Insurance Companies ,, HA...n the heels of an historic late night vote in the ...th care reform bill, the Pennsylvania AFL-CIO rele...atives voted on HR 3962, the Affordable Health Car...assed Saturday evening by a vote of 220 to 215, ta...
(Date:11/8/2009)...SNewswire/ -- March of Dimes hosted the Fourth Ann...ominent individuals who are celebrating the birth ...h of Dimes commitment to improve the health of bab...turity Awareness Month campaign, celebrities and s...emies! ,, (Photo: http://www.newscom.com/cgi-...
(Date:11/7/2009)...swire/ -- Speaker Nancy Pelosi spoke on the House...le Health Care for America Act. The House will vo...e Speaker,s remarks. ,, "Madam Speaker, today,...ion and for American families. For nearly a centu...y -- as far back as Teddy Roosevelt -- have called...
(Date:11/7/2009)... -- The American Medical Association (AMA) proudly...amily Violence Prevention Fund, with the Citation ... policy-making meeting. The Citation for Distingu...f Delegates bestows on a non-physician. ,, (L...09/AMALOGO ) ,, "Ms. James has worked selfles...
Breaking Medicine News(10 mins):Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Family Violence Prevention Expert 2
...tudy conducted by the researchers at the Imperial ...r from fewer allergic responses than the others//....ain animals prevent asthma and allergies. It was f...ective against eczema allergy. The study results a...
...TV commercial with fried eggs and the slogan 'This...d to discourage conventional //drug use among youn... finding new, inexpensive and more convenient ways...rugs like marijuana, cocaine and heroine. In fact,...
...ffect in an ostrich farm, after fears of avian att...hes//. The agriculture department is happy with t...tected the disease, and enabled timely control mea... avian influenza strain of virus is spared from th...
...decided to start a two year diploma courses in Yog...i Krishna Government// Ayurvedic College at Kuruks...rses has already been formulated and these courses...egrate allopathic system of medicines with Ayurved...
...n Americans and people with more education and hig...tween obesity //and anxiety disorders. Scienti...ve found a 25 % increased risk of getting anxiety ... obese person is about 25 percent more likely than...
...uthern Australian hospitals has been graded at the...e surgery admissions //and waiting times. Th...itals in the state having recorded the second high...y Abbott, who released a report on the nations pub...
Other Medicine News:Health News:Inhalants: The New, Convenient High for Kids and Teens 2Health News:Inhalants: The New, Convenient High for Kids and Teens 3Health News:Obesity, a Reflector of Mental Health – Study Find 2Health News:Obesity, a Reflector of Mental Health – Study Find 3Health News:South Australian health System In The Bottom Of Rankings 2
Crawford Fascia Stripper
Fluoroperm 151
Magniclear
...s of the Polycon II lens design with the exception...s a thin lens that offers predictable fitting, cri...s, durability and superior oxygen delivery. Combin...erior service and expedited delivery, Artcon is th...
Medicine Products: